To investigate the effects of hypoxia on radiosensitization by olaparib in vivo, subcutaneous Calu-6 and Calu-3 xenografts were established, and tumor hypoxia was assessed by IHC staining for CA9, a widely used intrinsic marker for tumor hypoxia (26). Here, CA9 is linked to neoplasm.